188 related articles for article (PubMed ID: 5973711)
1. [Antidysenteric vaccination. XIV. Immunizing action on the guinea pig conjunctiva of various toxic extracts of pathogenic Shigella flexneri 2a TI, as compared with that of live cultures of two non-pathogenic strains of Shigella flexneri 2a].
Istrati M; Istrati G
Arch Roum Pathol Exp Microbiol; 1966 Mar; 25(1):55-64. PubMed ID: 5973711
[No Abstract] [Full Text] [Related]
2. [Antidysentery vaccination. XI. a. Pathogenic action on the guinea pig intestine following the administration "per os" of Shigella flexneri 2a strains (pathogenic and non-pathogenic for guinea pig conjunctiva). b. Attempted immunization by oral route as compared to the intraperitoneal route].
Istrati G; Istrati M
Arch Roum Pathol Exp Microbiol; 1964 Sep; 23(3):721-30. PubMed ID: 5318791
[No Abstract] [Full Text] [Related]
3. [Anti-dysentery vaccination. X. Conjunctival vaccination of guinea pigs with non-pathogenic live Sh. flexneri 2a dysenteric bacilli].
Istrati G; Istrati M
Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):289-98. PubMed ID: 5877471
[No Abstract] [Full Text] [Related]
4. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes.
Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927
[No Abstract] [Full Text] [Related]
5. Technological aspect of the production of live dysentery vaccines for oral administration.
Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
[TBL] [Abstract][Full Text] [Related]
6. [Research on active immunity of man in bacillary dysentery. 3. Maintenance of the non-pathogenic character of the Shigella flexneri 2a TXXXII strain orally administered to volunteers].
Istrati G; Meitert T; Ciufeco C
Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):677-86. PubMed ID: 5877879
[No Abstract] [Full Text] [Related]
7. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
8. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals.
Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R
Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598
[No Abstract] [Full Text] [Related]
9. Efficiency of immunoprophylaxis and immunotherapy by live dysentery vaccine administration in children and adults collectivities.
Meitert T; Ciudin L; Pencu E; Tonciu M; Gheorghe G
Arch Roum Pathol Exp Microbiol; 1982; 41(4):357-69. PubMed ID: 6763515
[No Abstract] [Full Text] [Related]
10. [Anti-dysentery vaccination. 13. Immunogenicity of Sh. flexneri 2A as compared with the immunogenicity of a keratoconjunctivitis-positive enterobacterium devoid of Shigella antigens. Preliminary note].
Ciufeco C; Grigoresco E; Istrati G
Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):669-76. PubMed ID: 5877878
[No Abstract] [Full Text] [Related]
11. [Anti-dysentery vaccination. 8. Conjunctival vaccination of guinea pigs with non-pathogenic live dysenteric bacilli. Preliminary note].
Istrati G; Istrati M
Arch Roum Pathol Exp Microbiol; 1964 Mar; 23(1):91-3. PubMed ID: 5877144
[No Abstract] [Full Text] [Related]
12. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
[No Abstract] [Full Text] [Related]
13. An experimental study of postvaccination and postinfectious immunity to dysenteria in guinea-pigs.
Manolov DG; Kosturkov GB
J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):347-52. PubMed ID: 5629951
[No Abstract] [Full Text] [Related]
14. Protective immunity by oral immunization with heat-killed Shigella strains in a guinea pig colitis model.
Barman S; Koley H; Ramamurthy T; Chakrabarti MK; Shinoda S; Nair GB; Takeda Y
Microbiol Immunol; 2013 Nov; 57(11):762-71. PubMed ID: 24033533
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
16. Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial.
Mel DM; Terzin AL; Vuksić L
Bull World Health Organ; 1965; 32(5):647-55. PubMed ID: 5294180
[TBL] [Abstract][Full Text] [Related]
17. [Oral vaccination using live, apathogenic nondependent Shigella organisms].
Meitert T; Istrati G; Ciufecu C; Sulea IT
Z Gesamte Hyg; 1972 Oct; 18(10):753-6. PubMed ID: 4581672
[No Abstract] [Full Text] [Related]
18. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
[No Abstract] [Full Text] [Related]
19. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Phalipon A; Sansonetti P
Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
